Literature DB >> 25553322

Comparison of long-term results of above-the-knee femoro-popliteal bypass with autogenous vein and polytetrafluoroethylene grafts.

Seon-Hee Heo1, Yang-Jin Park1, Shin-Young Woo1, Dong-Ik Kim1, Young-Wook Kim1.   

Abstract

PURPOSE: To analyze the long-term results of above-the-knee femoro-popliteal bypass (ATKFPB) with vein grafts compared with polytetrafluoroethylene (PTFE) grafts.
METHODS: A database of patients with chronic atherosclerotic occlusive disease who underwent ATKFPB was retrospectively reviewed. Characteristics of patient and arterial lesion, and follow-up results were compared between vein grafts and PTFE grafts. Graft patency was determined by periodic examinations of duplex ultrasonography or CT angiograms. Graft patency and limb salvage rates were calculated using the Kaplan-Meier method.
RESULTS: In total, 253 ATKFPBs (107 vein grafts; 146 PTFE grafts; critical limb ischemia, 32%) were performed on 228 patients (mean age, 68.5 years; male, 87.7%). No significant differences were observed between the two groups with respect to demographic characteristics, characteristics of arterial lesions, or distal runoff score. During the mean follow-up period of 41 months (range, 1-122 months), 14.5% patients died, and 94% of all limbs were available for follow-up. The primary patency rates were not significantly different between the two groups at 10 years after treatment (75% vs. 42%, P = 0.330). However, the primary-assisted patency rates (88% vs. 42%, P = 0.003) and secondary patency rates (91% vs. 49%, P = 0.013) were significantly higher in the vein grafts compared with the PTFE grafts. Graft occlusion developed more often in the PTFE grafts (5.6% vs. 20.5%, P = 0.001). When graft occlusion occurred, acute limb ischemia was significantly more frequent in the PTFE grafts than in the vein grafts (0% vs. 53%, P = 0.027).
CONCLUSION: After ATKFPB, autologous vein grafts showed significantly better long-term results compared with PTFE grafts.

Entities:  

Keywords:  Comparative study; Peripheral arterial occlusive disease; Vascular graft occlusion

Year:  2014        PMID: 25553322      PMCID: PMC4279987          DOI: 10.4174/astr.2015.88.1.28

Source DB:  PubMed          Journal:  Ann Surg Treat Res        ISSN: 2288-6575            Impact factor:   1.859


  24 in total

1.  Prosthetic above-knee femoropopliteal bypass grafting: five-year results of a randomized trial.

Authors:  R M Green; W M Abbott; T Matsumoto; J R Wheeler; N Miller; F J Veith; S Money; H E Garrett
Journal:  J Vasc Surg       Date:  2000-03       Impact factor: 4.268

2.  Current efficacy of open and endovascular interventions for advanced superficial femoral artery occlusive disease.

Authors:  Christopher J Smolock; Javier E Anaya-Ayala; Yoav Kaufman; Charudatta S Bavare; Mitul S Patel; Hosam F El-Sayed; Alan B Lumsden; Mark G Davies
Journal:  J Vasc Surg       Date:  2013-11       Impact factor: 4.268

3.  Should vein be saved for future operations? A 15-year review of infrainguinal bypasses and the subsequent need for autogenous vein.

Authors:  L F Poletti; J H Matsuura; J B Dattilo; M P Posner; H M Lee; M Scouvart; M Sobel
Journal:  Ann Vasc Surg       Date:  1998-03       Impact factor: 1.466

4.  Recommended standards for reports dealing with lower extremity ischemia: revised version.

Authors:  R B Rutherford; J D Baker; C Ernst; K W Johnston; J M Porter; S Ahn; D N Jones
Journal:  J Vasc Surg       Date:  1997-09       Impact factor: 4.268

5.  Saphenous vein or PTFE for femoropopliteal bypass. A prospective randomized trial.

Authors:  H W Tilanus; H Obertop; H Van Urk
Journal:  Ann Surg       Date:  1985-12       Impact factor: 12.969

6.  Prospective controlled study of polytetrafluoroethylene versus saphenous vein in claudicant patients with bilateral above knee femoropopliteal bypasses.

Authors:  A F AbuRahma; P A Robinson; S M Holt
Journal:  Surgery       Date:  1999-10       Impact factor: 3.982

7.  Seven-year experience with polytetrafluoroethylene as above-knee femoropopliteal bypass graft. Is is worthwhile to preserve the autologous saphenous vein?

Authors:  A V Sterpetti; R D Schultz; R J Feldhaus; D J Peetz
Journal:  J Vasc Surg       Date:  1985-11       Impact factor: 4.268

8.  Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting: five-year results of a randomized controlled trial.

Authors:  Pieter Klinkert; Abbey Schepers; Desirée H C Burger; J Hajo van Bockel; Paul J Breslau
Journal:  J Vasc Surg       Date:  2003-01       Impact factor: 4.268

9.  Randomization of autogenous vein and polytetrafluorethylene grafts in femoral-distal reconstruction.

Authors:  J J Bergan; F J Veith; V M Bernhard; J S Yao; W R Flinn; S K Gupta; L A Scher; R H Samson; J B Towne
Journal:  Surgery       Date:  1982-12       Impact factor: 3.982

10.  Treatment of failing vein grafts in patients who underwent lower extremity arterial bypass.

Authors:  Keun-Myoung Park; Yang Jin Park; Shin-Seok Yang; Dong-Ik Kim; Young-Wook Kim
Journal:  J Korean Surg Soc       Date:  2012-10-29
View more
  1 in total

1.  Factors associated with long-term graft patency after lower extremity arterial bypasses.

Authors:  Ki-Sang Jung; Seon-Hee Heo; Shin-Young Woo; Yang-Jin Park; Dong-Ik Kim; Young-Wook Kim
Journal:  Ann Surg Treat Res       Date:  2021-02-26       Impact factor: 1.859

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.